Free Trial

Bath & Body Works (NYSE:BBWI) Releases Q2 2024 Earnings Guidance

Bath & Body Works logo with Retail/Wholesale background

Bath & Body Works (NYSE:BBWI - Get Free Report) issued an update on its second quarter 2024 earnings guidance on Tuesday morning. The company provided EPS guidance of 0.310-0.360 for the period, compared to the consensus EPS estimate of 0.390. The company issued revenue guidance of $1.5 billion-$1.6 billion, compared to the consensus revenue estimate of $1.5 billion. Bath & Body Works also updated its FY 2024 guidance to 3.050-3.350 EPS.

Analysts Set New Price Targets

A number of research firms have commented on BBWI. JPMorgan Chase & Co. upgraded shares of Bath & Body Works from an underweight rating to a neutral rating and boosted their price target for the company from $40.00 to $53.00 in a research report on Friday, May 17th. UBS Group upped their price target on shares of Bath & Body Works from $46.00 to $52.00 and gave the stock a neutral rating in a research report on Monday, March 4th. Wells Fargo & Company upped their price target on shares of Bath & Body Works from $42.00 to $48.00 and gave the stock an equal weight rating in a research report on Wednesday, April 24th. The Goldman Sachs Group raised their target price on shares of Bath & Body Works from $49.00 to $56.00 and gave the stock a buy rating in a research note on Monday, March 4th. Finally, TD Cowen raised their target price on shares of Bath & Body Works from $35.00 to $55.00 and gave the stock an outperform rating in a research note on Friday, March 1st. Eight research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to MarketBeat.com, Bath & Body Works presently has a consensus rating of Hold and an average target price of $48.20.

Check Out Our Latest Stock Analysis on Bath & Body Works


Bath & Body Works Trading Down 12.6 %

BBWI stock traded down $6.53 during mid-day trading on Tuesday, hitting $45.28. The stock had a trading volume of 11,468,159 shares, compared to its average volume of 2,759,262. Bath & Body Works has a 52 week low of $27.30 and a 52 week high of $52.99. The firm has a market capitalization of $10.13 billion, a P/E ratio of 11.76, a P/E/G ratio of 1.67 and a beta of 1.90. The firm has a fifty day simple moving average of $47.22 and a 200 day simple moving average of $44.03.

Bath & Body Works Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 21st. Shareholders of record on Friday, June 7th will be issued a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 1.77%. The ex-dividend date of this dividend is Friday, June 7th. Bath & Body Works's payout ratio is 20.78%.

Insider Transactions at Bath & Body Works

In related news, insider Thomas E. Mazurek sold 4,285 shares of the business's stock in a transaction on Wednesday, March 27th. The shares were sold at an average price of $48.89, for a total transaction of $209,493.65. Following the transaction, the insider now owns 45,992 shares in the company, valued at approximately $2,248,548.88. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.27% of the company's stock.

Bath & Body Works Company Profile

(Get Free Report)

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.

Further Reading

Earnings History and Estimates for Bath & Body Works (NYSE:BBWI)

→ Collapse of the Petrodollar (From Colonial Metals) (Ad)

Should you invest $1,000 in Bath & Body Works right now?

Before you consider Bath & Body Works, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.

While Bath & Body Works currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

3 Strong Buy Stocks for a Summer Surge

3 Strong Buy Stocks for a Summer Surge

In this video, we break down the factors driving the market's impressive performance and why the S&P could rise another 15% by year's end.

Related Videos

GameStop Mania: Which Meme Stocks Will Follow?
5 Hottest CEO Stock Purchases
5 Tech Stocks to Buy Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines